about
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and DenmarkLimited impact of EU paediatric regulation on Finnish clinical trials highlights need for Nordic collaboration.Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient.Long Term Outcomes of Cord Blood Transplantation From an HLA-Identical Sibling for Patients with Bone Marrow Failure Disorders: a Report From Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the EuropeanFertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?Polyomaviruses BK, JC, KI, WU, MC, and TS in children with allogeneic hematopoietic stem cell transplantation.Human herpesvirus-6 and -7 in pediatric stem cell transplantation.Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.Viremic co-infections in children with allogeneic haematopoietic stem cell transplantation are predominated by human polyomaviruses.Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumours.Surgically treated patients with axial and peripheral Ewing's sarcoma family of tumours: A population based study in Finland during 1990-2009.Xanthine oxidase during human fetal development.Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.T cell regeneration in pediatric allogeneic stem cell transplantation.High prevalence of sacrococcygeal teratoma in Finland - a nationwide population-based study.Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report.Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation.Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia.Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow TranSpeckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.Germ cell tumors in children and adolescents in Finland: trends over 1969-2008.Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients.Good responses but high TRM in adult patients after MSC therapy for GvHD.Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study.The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland.A high circulating copy number of HHV-6 due to chromosomal integration in a child with acute lymphoblastic leukemia.Pulmonary function following allogeneic stem cell transplantation in childhood: a retrospective cohort study of 51 patients.Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT.Adenine nucleotide catabolism in the human trophoblast early and late in gestation.Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.
P50
Q35611455-8B4B23DB-4D31-42F8-A350-4FFBC9A9ED8CQ37406593-A3A8C78D-8036-4DB9-9537-F9D4343B50CDQ38124376-7B315BEE-5044-4C3A-AF6E-5DDB2B17DB64Q38301325-48B2F4E8-740B-4A09-9A0E-8B985D8922ECQ38629971-C7DCED8F-8CB8-433B-9A45-F608B20A02D0Q38652761-AB0A3C4B-128A-4681-94DB-1C506802F484Q38665733-18CC6DB9-DC19-4961-8B85-0DC0C4B8051FQ39570917-BF7CFDE4-43EA-42BD-8F4D-C07B8396C182Q39869601-A4BA69C2-688A-4869-BD1B-0DA46B16F338Q40515277-A238A9C3-3590-422F-8A3E-AA0B54F4CDADQ40575185-2D4208CF-A5F9-47CB-9A8C-813DE039A2FFQ40597442-2008A697-397A-488F-A3BA-B53855129591Q40810017-7C25ABE6-D128-4089-A2A9-2AD712D882CBQ41147250-4A4FF2E6-48E8-41D2-BDF6-E9E71D9E84C7Q43480404-4241E470-A12C-4EFB-B8DA-56FA672C9396Q43913723-F9F2DB79-1A54-412F-B910-CBA6ED9F81D3Q44097382-BFBFDFD4-6122-4331-BAEE-ED7E397A8F1DQ44272147-8241D9CE-B556-4651-8FAD-4C036846E267Q44372828-82965D22-722C-4C16-8D10-58FA50B5B870Q45835453-0542271A-4AD9-4B2C-AC4F-FA96CC0E38CBQ46068589-5BB8249D-6BC5-4FF3-8F42-FD8B898938B7Q47243263-C5604237-10D8-4B34-8D41-82683FC1E2E6Q47442393-A8C6B391-8135-49A1-95C7-A5884B9AAE6FQ47619766-D1EE9FC8-38C8-4074-8D2C-3C11DA9CE557Q47959792-DBF1D139-9A99-403D-A905-C5263E79191AQ48135567-92259118-736C-470C-A150-F15DDB769DF5Q48358641-5523D2DC-51FA-4746-8AC4-7C2595504CB2Q48457118-4B6253A3-9923-4BBE-985E-F3C0F135D882Q48638499-5DB0B588-C2F3-4CE6-8244-DC274C5AAB47Q50200953-FDBB4AB0-6C8F-4D61-A124-95A1EDFCDD5BQ50221557-1774C05F-6695-4AD7-B92F-E726F0E1E4ECQ50690561-CD6D2600-2A03-4CF0-8545-3B8B14F0E596Q50894700-9C7AD047-FC66-4C7A-8123-922030EA024BQ51193447-80E2508D-E7A8-4EF6-90E8-ECAC1FA01753Q51556135-3FD09CD4-68AA-4F9B-A650-BCEDD46805F4Q51709463-77595D5B-E5AC-4207-B3B3-267000937144Q51772466-A0D02EFA-050F-4EB9-9B32-F34C8BB77480Q51874195-A7A48D73-84D3-48FB-B81A-D90E2CFA1873Q52460699-4C96382F-799E-48C5-B0CC-316EFE82B33BQ53172232-3A7296F2-202B-4F51-863F-5ADB45E7FCC9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kim Vettenranta
@ast
Kim Vettenranta
@en
Kim Vettenranta
@es
Kim Vettenranta
@nl
Kim Vettenranta
@sl
type
label
Kim Vettenranta
@ast
Kim Vettenranta
@en
Kim Vettenranta
@es
Kim Vettenranta
@nl
Kim Vettenranta
@sl
prefLabel
Kim Vettenranta
@ast
Kim Vettenranta
@en
Kim Vettenranta
@es
Kim Vettenranta
@nl
Kim Vettenranta
@sl
P106
P31
P496
0000-0002-8535-0135